These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20598107)

  • 1. High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron.
    Birgegård G; Schneider K; Ulfberg J
    Vox Sang; 2010 Nov; 99(4):354-61. PubMed ID: 20598107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the response to intravenous iron in restless legs syndrome: an observational study.
    Hornyak M; Scholz H; Kiemen A; Kassubek J
    Sleep Med; 2012 Jun; 13(6):732-5. PubMed ID: 22503006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome.
    Grote L; Leissner L; Hedner J; Ulfberg J
    Mov Disord; 2009 Jul; 24(10):1445-52. PubMed ID: 19489063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose.
    Grim K; Lee B; Sung AY; Kotagal S
    Sleep Med; 2013 Nov; 14(11):1100-4. PubMed ID: 23993871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron dextran for severe refractory restless legs syndrome.
    Ondo WG
    Sleep Med; 2010 May; 11(5):494-6. PubMed ID: 20371212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin.
    Vadasz D; Ries V; Oertel WH
    Sleep Med; 2013 Nov; 14(11):1214-6. PubMed ID: 24012019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
    Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ
    Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome in blood donors.
    Ulfberg J; Nyström B
    Sleep Med; 2004 Mar; 5(2):115-8. PubMed ID: 15033129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restless legs syndrome in Indian patients having iron deficiency anemia in a tertiary care hospital.
    Rangarajan S; D'Souza GA
    Sleep Med; 2007 Apr; 8(3):247-51. PubMed ID: 17368978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of restless legs syndrome in blood donors.
    Arunthari V; Kaplan J; Fredrickson PA; Lin SC; Castillo PR; Heckman MG
    Mov Disord; 2010 Jul; 25(10):1451-5. PubMed ID: 20629149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
    Deng Y; Wu J; Jia Q
    Med Sci Monit; 2017 Mar; 23():1254-1260. PubMed ID: 28285317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower molecular weight intravenous iron dextran for restless legs syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2013 Mar; 14(3):274-7. PubMed ID: 23333678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron metabolism and the risk of restless legs syndrome in an elderly general population--the MEMO-Study.
    Berger K; von Eckardstein A; Trenkwalder C; Rothdach A; Junker R; Weiland SK
    J Neurol; 2002 Sep; 249(9):1195-9. PubMed ID: 12242538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
    Macher S; Drexler C; Lindenau I; Sareban N; Schlenke P; Amrein K
    Trials; 2016 Oct; 17(1):527. PubMed ID: 27793204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of regular LDL apheresis on the development of restless legs syndrome.
    Tings T; Schettler V; Canelo M; Paulus W; Trenkwalder C
    Mov Disord; 2004 Sep; 19(9):1072-5. PubMed ID: 15372599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors.
    Högl B; Kiechl S; Willeit J; Saletu M; Frauscher B; Seppi K; Müller J; Rungger G; Gasperi A; Wenning G; Poewe W
    Neurology; 2005 Jun; 64(11):1920-4. PubMed ID: 15955944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome.
    Bryant BJ; Yau YY; Arceo SM; Hopkins JA; Leitman SF
    Transfusion; 2013 Aug; 53(8):1637-44. PubMed ID: 23305102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
    Macher S; Herster C; Holter M; Moritz M; Matzhold EM; Stojakovic T; Pieber TR; Schlenke P; Drexler C; Amrein K
    Nutrients; 2020 May; 12(5):. PubMed ID: 32380660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of oral iron treatment in pediatric restless legs syndrome (RLS).
    Mohri I; Kato-Nishimura K; Kagitani-Shimono K; Kimura-Ohba S; Ozono K; Tachibana N; Taniike M
    Sleep Med; 2012 Apr; 13(4):429-32. PubMed ID: 22341906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of donor history of restless leg syndrome and pica to asses iron deficiency.
    Singh A; Chaudhary R; Sonker A; Pandey HC
    Transfus Apher Sci; 2016 Apr; 54(2):259-61. PubMed ID: 26482524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.